Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

PURPOSE: Assess follow-up treatment and clinical outcomes at 5 years in eyes initially treated with anti-VEGF therapy for center involved diabetic macular edema (CI-DME) in a 2-year randomized clinical trial. DESIGN: Multicenter cohort study. PARTICIPANTS: Participants with DME and visual acuity (VA...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ophthalmology
Huvudupphovsmän: Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483366/
https://ncbi.nlm.nih.gov/pubmed/32402554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2020.03.021
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk